Angioedema Newswire

Angioedema Newswire

Comprehensive Real-Time News Feed for Angioedema.

Results 1 - 3 of 4 in Angioedema

  1. Dr. Roach: Rare condition causes swelling, GI distressRead the original story w/Photo

    Jun 15, 2016 | Lubbock Avalanche-Journal

    Dear Dr. Roach: I am a 63-year-old male who was diagnosed with hereditary angioedema about 16 months ago. I use Firazyr injection when I have an attack.

    Comment?

  2. Stock Plunges as Biocryst's Angioedema Drug Flunks Phase II StudyRead the original story

    Feb 7, 2016 | BioSpace

    BioCryst Pharmaceuticals, Inc. , today announced results from OPuS-2 , a clinical trial of avoralstat administered three times daily as a liquid-filled soft gel formulation for the prophylactic treatment of hereditary angioedema attacks. In the OPuS-2 study, HAE patients with a historical attack frequency of greater than 0.45 attacks per week were randomized to treatment with either 500 mg or 300 mg of avoralstat, or placebo, administered three times daily for 12 weeks.

    Comment?

  3. Dyax shares jump as antitrust waiting period for Shire acquisition endsRead the original story w/Photo

    Dec 2, 2015 | MarketWatch

    ... is offering $37.30 a share for Dyax, along with another $4 a share with the approval of Dyax's DX-2930 hereditary angioedema treatment.

    Comment?